Best Practices in Developing Proprietary Names for Drugs

First Page		Document Content
Health Pharmaceuticals policy Food and Drug Administration Medical research Names Healthcare quality Patient safety United States Adopted Name Prescription Drug User Fee Act Over-the-counter drug Medical prescription International nonproprietary name		Best Practices in Developing Proprietary Names for Drugs Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 279,00 KB Share Document on Facebook

	Capital Reporting Company Public Meeting on PDUFA VIU.S. FOOD & DRUG ADMINISTRATION PRESCRIPTION DRUG USER FEE ACT DocID: 1t0K4 - View Document
	Prescription Drug User Fee Act (PDUFA) Reauthorization Public Meeting August 15, 2016 1 Basic PDUFA Construct DocID: 1sUEh - View Document
	Prescription Drug User Fee Act (PDUFA) Reauthorization August 15, 2016 Page 1 1 FOOD AND DRUG ADMINISTRATION (FDA) DocID: 1sUz3 - View Document
	United States Government Accountability Office GAO Testimony Before the Subcommittee on Oversight DocID: 1rfHg - View Document
	Best Practices in Developing Proprietary Names for Drugs DocID: 1r8R5 - View Document